Vivos Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:VVOS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -3.8 M-3.49 M-4.16 M-3.81 M-6.01 M -17.48 M Cash from investing activities -122 K-5.91 M83 K-1.58 M-18 K -7.42 M Cash from financing activities 011.46 M2.76 M4.33 M6.11 M 24.67 M Free cash flow -3.8 M-3.49 M-4.16 M-3.81 M-6.01 M -17.48 M

News

Plus Therapeutics (PSTV) Reports Q1 Loss, Tops Revenue Estimates

Vivos Therapeutics, Inc. (VVOS) Q4 2025 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NRXP) Surpasses Q4 Earnings Estimates

Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates

Health Catalyst (HCAT) Lags Q4 Earnings Estimates

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Certara (NASDAQ:CERT), Vivos Therapeutics (NASDAQ:VVOS)

Vivos Therapeutics announces $4.64 million warrant exercise deal

Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know

Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript

Vivos opens new sleep center in Michigan, expanding national footprint

Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript